Publications by authors named "Ina Haendle"

Claim this Profile
T
Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients.
Stefanie Gross, Michael Erdmann, Ina Haendle, Steve Voland, Thomas Berger

JCI Insight· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Denileukin diftitox (ONTAK) induces a tolerogenic phenotype in dendritic cells and stimulates survival of resting Treg.
Andreas S Baur, Manfred B Lutz, Stephan Schierer, Luca Beltrame, Gabi Theiner, Ina Haendle

Blood· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-reactive CD4+ T cell responses to the melanoma-associated chondroitin sulphate proteoglycan in melanoma patients and healthy individuals in the absence of autoimmunity.
Cornelia Erfurt, Zhaojun Sun, Ina Haendle, Beatrice Schuler-Thurner, Carlo Heirman

J Immunol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulation and homing of melanoma-reactive T cells to both cutaneous and visceral metastases after vaccination with monocyte-derived dendritic cells.
Thomas G Berger, Ina Haendle, David Schrama, Matthias Lüftl, Nicolas Bauer

Int J Cancer· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis